These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 9888981)
1. Isolation of multiple distinct cDNAs by a single cDNA-trapping procedure. Hu M; Yan B Anal Biochem; 1999 Jan; 266(2):233-5. PubMed ID: 9888981 [No Abstract] [Full Text] [Related]
2. Genetic susceptibility to hemorrhagic complications during warfarin therapy. Tabrizi AR; Freeman BD; Buchman TG; Zehnbauer BA Surgery; 2001 May; 129(5):645-6. PubMed ID: 11331459 [No Abstract] [Full Text] [Related]
3. Warfarin therapy in a patient homozygous for the CYP2C9 3 allele. Ablin J; Cabili S; Lagziel A; Peretz H Isr Med Assoc J; 2002 Feb; 4(2):139-41. PubMed ID: 11875991 [No Abstract] [Full Text] [Related]
4. Reply to rebuttal: Gene variants of the cytochrome P450 CYP2C9 affect oral anticoagulation with warfarin. Margaglione M; Brancaccio V; Ciampa A; Di Minno G Thromb Haemost; 2001 Sep; 86(3):938. PubMed ID: 11583336 [No Abstract] [Full Text] [Related]
10. Sphingolipid-dependent signaling in regulation of cytochrome P450 expression. Morgan ET; Nikolova-Karakashian M; Chen JQ; Merrill AH Methods Enzymol; 1996; 272():381-8. PubMed ID: 8791797 [No Abstract] [Full Text] [Related]
11. [Effect of inducers on the interaction of positive and negative cis-active elements of the CYP2B2 gene with nuclear proteins in rat liver]. Shvarts EI; Duzhak TG; Guliaeva LF; Liakhovich VV Mol Biol (Mosk); 2000; 34(3):413-8. PubMed ID: 10867919 [No Abstract] [Full Text] [Related]
12. Effects of disease on expression and regulation of CYPs. Farrell G Mol Aspects Med; 1999; 20(1-2):55-70, 137. PubMed ID: 10575652 [No Abstract] [Full Text] [Related]
13. Cloning and expression analysis of a new member of the cytochrome P450, CYP2A15 from the Chinese hamster, encoding testosterone 7alpha-hydroxylase. Kurose K; Isozaki E; Tohkin M; Fukuhara M Arch Biochem Biophys; 1999 Nov; 371(2):270-6. PubMed ID: 10545214 [TBL] [Abstract][Full Text] [Related]
14. CYP2C9 is a principal low-affinity phenacetin O-deethylase: fluvoxamine is not a specific CYP1A2 inhibitor. Venkatakrishnan K; von Moltke LL; Greenblatt DJ Drug Metab Dispos; 1999 Dec; 27(12):1519-22. PubMed ID: 10627170 [No Abstract] [Full Text] [Related]
15. Cloning of a cDNA encoding a novel cytochrome P450 from the insect Locusta migratoria: CYP6H1, a putative ecdysone 20-hydroxylase. Winter J; Bilbe G; Richener H; Sehringer B; Kayser H Biochem Biophys Res Commun; 1999 Jun; 259(2):305-10. PubMed ID: 10362503 [TBL] [Abstract][Full Text] [Related]
16. Rapid detection of CYP2C9*3 alleles by real-time fluorescence PCR based on SYBR Green. Hiratsuka M; Agatsuma Y; Mizugaki M Mol Genet Metab; 1999 Nov; 68(3):357-62. PubMed ID: 10562462 [TBL] [Abstract][Full Text] [Related]
17. Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population. Yasar U; Eliasson E; Dahl ML; Johansson I; Ingelman-Sundberg M; Sjöqvist F Biochem Biophys Res Commun; 1999 Jan; 254(3):628-31. PubMed ID: 9920790 [TBL] [Abstract][Full Text] [Related]
19. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Lund EG; Guileyardo JM; Russell DW Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7238-43. PubMed ID: 10377398 [TBL] [Abstract][Full Text] [Related]
20. Isolation of cDNA clones by complementation of E. coli mutants with infective pBluescript phagemid libraries. Williamson CL; Slocum RD Biotechniques; 1994 Jun; 16(6):986-8. PubMed ID: 8074882 [No Abstract] [Full Text] [Related] [Next] [New Search]